These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33008561)

  • 1. Prostaglandin-Associated Periorbitopathy in Children and Young Adults with Glaucoma.
    Kim JS; Blizzard S; Woodward JA; Leyngold IM; Liss J; Freedman SF
    Ophthalmol Glaucoma; 2020; 3(4):288-294. PubMed ID: 33008561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unilateral Prostaglandin-Associated Periorbitopathy: A Syndrome Involving Upper Eyelid Retraction Distinguishable From the Aging Sunken Eyelid.
    Rabinowitz MP; Katz LJ; Moster MR; Myers JS; Pro MJ; Spaeth GL; Sharma P; Stefanyszyn MA
    Ophthalmic Plast Reconstr Surg; 2015; 31(5):373-8. PubMed ID: 25393907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eyelid and eyelash changes due to prostaglandin analog therapy in unilateral treatment cases.
    Yoshino T; Fukuchi T; Togano T; Seki M; Ikegaki H; Abe H
    Jpn J Ophthalmol; 2013 Mar; 57(2):172-8. PubMed ID: 23208023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periorbital changes associated with prostaglandin analogs in Korean patients.
    Kim HW; Choi YJ; Lee KW; Lee MJ
    BMC Ophthalmol; 2017 Jul; 17(1):126. PubMed ID: 28716077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periocular skin hyperpigmentation in children treated with prostaglandin analogues.
    Al-Zobidi M; Khandekar R; Craven ER; Hanafi S; Edward DP
    J AAPOS; 2015 Feb; 19(1):49-53. PubMed ID: 25727587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Related to Prostaglandin-Associated Periorbitopathy in Glaucoma Patients.
    Patradul C; Tantisevi V; Manassakorn A
    Asia Pac J Ophthalmol (Phila); 2017; 6(3):238-242. PubMed ID: 28379653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association of Chronic Topical Prostaglandin Analog Use With Meibomian Gland Dysfunction.
    Mocan MC; Uzunosmanoglu E; Kocabeyoglu S; Karakaya J; Irkec M
    J Glaucoma; 2016 Sep; 25(9):770-4. PubMed ID: 27513901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma.
    Sakata R; Fujishiro T; Saito H; Nakamura N; Honjo M; Shirato S; Miyamoto E; Yamada Y; Aihara M
    J Ocul Pharmacol Ther; 2023; 39(1):63-69. PubMed ID: 36318495
    [No Abstract]   [Full Text] [Related]  

  • 9. Do Prostaglandin Analogue Lash Lengtheners Cause Eyelid Fat and Volume Loss?
    Jamison A; Okafor L; Ullrich K; Schiedler V; Malhotra R
    Aesthet Surg J; 2022 Oct; 42(11):1241-1249. PubMed ID: 35700523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deepening of eyelid superior sulcus during topical travoprost treatment.
    Yang HK; Park KH; Kim TW; Kim DM
    Jpn J Ophthalmol; 2009 Mar; 53(2):176-179. PubMed ID: 19333704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost.
    Kucukevcilioglu M; Bayer A; Uysal Y; Altinsoy HI
    Clin Exp Ophthalmol; 2014 Mar; 42(2):126-31. PubMed ID: 23844550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin analogues: A double-edged sword in orbital glaucoma disease management.
    Joganathan V; Cannon PS; Mercieca K
    Eur J Ophthalmol; 2021 May; 31(3):NP40-NP44. PubMed ID: 32043370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observations on Prostaglandin Orbitopathy.
    Custer PL; Kent TL
    Ophthalmic Plast Reconstr Surg; 2016; 32(2):102-5. PubMed ID: 25719374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deepening of the upper eyelid sulcus caused by 5 types of prostaglandin analogs.
    Inoue K; Shiokawa M; Wakakura M; Tomita G
    J Glaucoma; 2013; 22(8):626-31. PubMed ID: 22936280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low incidence of iris pigmentation and eyelash changes in 2 randomized clinical trials with unoprostone isopropyl 0.15%.
    McCarey BE; Kapik BM; Kane FE;
    Ophthalmology; 2004 Aug; 111(8):1480-8. PubMed ID: 15288975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periocular mexametric melanin and erythema indexes in adult glaucoma patients treated with topical prostaglandin analogs.
    Duman N; Duman R; Yavaş GF; Doğruk Kaçar S; Özuğuz P; Çetinkaya E
    Cutan Ocul Toxicol; 2017 Mar; 36(1):9-11. PubMed ID: 26911512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of Prostaglandin-Associated Periorbitopathy after Discontinuing Treatment.
    Abalo-Lojo JM; Ferreiro PV; Asorey MK; Colmenero AE; Gonzalez F
    Turk J Ophthalmol; 2023 Feb; 53(1):8-12. PubMed ID: 36847619
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    DI Staso S; Agnifili L; Cecannecchia S; DI Gregorio A; Ciancaglini M
    In Vivo; 2018; 32(2):211-220. PubMed ID: 29475902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Side-effects and risk profile of latanoprost 0.005% (Xalatan)].
    Schlote T
    Ophthalmologe; 2002 Sep; 99(9):724-9. PubMed ID: 12219263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretarsal skin height changes in children receiving topical prostaglandin analogue therapy for primary congenital glaucoma.
    Al-Zobidi M; Khandekar R; Cruz A; Craven RE; Souru C; Malik R; Edward DP
    J AAPOS; 2018 Aug; 22(4):290-293.e1. PubMed ID: 29792934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.